MacroGenics
MGNX
#8650
Rank
A$0.33 B
Marketcap
A$5.28
Share price
-7.73%
Change (1 day)
107.87%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : A$30.25 Million

According to MacroGenics's latest financial reports the company has A$30.25 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$82.99 M-55.52%
2024-12-31$A$0.18 B-16.7%
2023-12-31$A$0.22 B7.34%
2022-12-31$A$0.20 B-36.86%
2021-12-31$A$0.33 B-14.11%
2020-12-31$A$0.38 B16.82%
2019-12-31$A$0.32 B-4.46%
2018-12-31$A$0.34 B-10.05%
2017-12-31$A$0.38 B2.8%
2016-12-31$A$0.37 B-13.32%
2015-12-31$A$0.43 B190.23%
2014-12-31$A$0.14 B67.51%
2013-12-31$A$88.47 M-1216.12%
2012-12-31$-A$7.93 Million-53.52%
2011-12-31$-A$17.06 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$129.04 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.53 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.11 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$33.44 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$65.56 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.69 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.73 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA